慢阻肺急性加重的多层次差异网络分析
该概念验证研究纳入西班牙86例慢阻肺急性加重住院患者,在住院72小时内及出院至少3个月稳定期进行多层次(临床、生理、生物、影像、微生物)特征刻画。研究发现急性加重期存在恢复期相关性网络的破坏,且呼吸困难加重、循环中性粒细胞和C反应蛋白(CRP)三个生物标志物组合对急性加重诊断有高预测价值(AUC 0.97)。
要点
- 慢阻肺急性加重期存在多层次网络稳态破坏,恢复期网络相关性消失。
- 呼吸困难、循环中性粒细胞和CRP三联标志物对急性加重诊断预测价值高(AUC 0.97)。
- 该三联标志物均为临床常规检测指标,可客观辅助急性加重识别。
核心结论
- 慢阻肺急性加重以恢复期存在的网络稳态破坏为特征。
- 呼吸困难、循环中性粒细胞和CRP三联标志物可客观识别慢阻肺急性加重。
研究设计与样本
- 概念验证研究,纳入西班牙多中心86例因慢阻肺急性加重住院的患者。
- 患者在住院最初72小时内及出院至少3个月临床稳定期接受多层次全面特征刻画。
主要发现
- 急性加重期表现为恢复期观察到的网络相关性破坏。
- 包含呼吸困难加重、循环中性粒细胞和CRP升高的生物标志物组合对急性加重诊断具有高预测价值(AUC 0.97)。
关键数值与推荐
- 三联生物标志物组合诊断慢阻肺急性加重的AUC为0.97。
- 生物标志物包括呼吸困难水平升高、循环中性粒细胞和CRP。
临床怎么用
- 可利用临床常规检测的呼吸困难、循环中性粒细胞和CRP三联标志物客观辅助慢阻肺急性加重诊断。
- 网络分析思路有助于理解慢阻肺急性加重的复杂病理生物学。
局限性
- 本研究为概念验证研究,样本量86例,结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with chronic obstructive pulmonary disease (COPD) often suffer episodes of exacerbation (ECOPD) that impact negatively the course of their disease. ECOPD are heterogeneous events of unclear pathobiology and non-specific diagnosis. Network analysis is a novel research approach that can help unravelling complex biological systems. We hypothesised that the comparison of multi-level (i.e., clinical, physiological, biological, imaging and microbiological) correlation networks determined during ECOPD and convalescence can yield novel patho-biologic information.In this proof-of-concept study we included 86 patients hospitalised because of ECOPD in a multicentre study in Spain. Patients were extensively characterised both during the first 72 h of hospitalisation and during clinical stability, at least 3 months after hospital discharge.We found that 1) episodes of ECOPD are characterised by disruption of the network correlation observed during convalescence; and 2) a panel of biomarkers that include increased levels of dyspnoea, circulating neutrophils and C-reactive protein (CRP) has a high predictive value for ECOPD diagnosis (AUC 0.97).We conclude that ECOPD 1) are characterised by disruption of network homeokinesis that exists during convalescence; and 2) can be identified objectively by using a panel of three biomarkers (dyspnoea, circulating neutrophils and CRP levels) frequently determined in clinical practice.
引用
- Noell G, Cosío BG, Faner R, et al. Multi-level differential network analysis of COPD exacerbations. Eur Respir J. 2017. PMID: 28954781. doi:10.1183/13993003.00075-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。